Benjamin Drapkin, MD PhD
I am a translational lung cancer researcher and assistant professor of medicine at the University of Texas Southwestern Medical Center (UTSW). My laboratory, located in the Hamon Center for Therapeutic Oncology, focuses on small cell lung cancer (SCLC), an aggressive and common malignancy with a dismal prognosis of less than one year that has not improved significantly in the past 40 years. We leverage a large collection of patient-derived xenograft (PDX) models that closely recapitulate the clinical features of their corresponding patients to discover new molecular targets to treat this deadly disease. Our current areas of focus are (1) to develop strategies to overcome or circumvent chemotherapy cross-resistance, which renders relapsed SCLC refractory to further care, and (2) to elucidate the mechanism(s) that allow lineage transformation from lung adenocarcinoma into SCLC, which confers resistance to many oncogene-targeted therapies.
Financial relationships
-
Type of financial relationship:There are no financial relationships to disclose.Date added:08/28/2022Date updated:10/22/2024
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.